DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents
Showing 1 - 25 of >10,000
Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and
Not yet recruiting
- Disability or Chronic Disease Leading to Disablement
- +2 more
- Surgical flap and anti-bacterial agents
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia
Not yet recruiting
- Macular Degeneration, Age Related
- +4 more
- VISUPRIME
- Placebo
-
Perugia, PG, ItalyOspedale Santa Maria della Misericordia
Dec 22, 2022
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +4 more
-
West Hollywood, California
- +101 more
Jan 16, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Periodontal Pocket, Periodontitis Trial in Baghdad (ozone gel)
Completed
- Periodontal Pocket
- Periodontitis
- ozone gel
-
Baghdad, IraqGhufran Falih Hassen
Jun 7, 2023
Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)
Not yet recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
-
Duarte, California
- +1 more
Oct 13, 2023
Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)
Not yet recruiting
- Neovascular Age-related Macular Degeneration(nAMD)
- HG202
-
Shanghai, Shanghai, China
- +1 more
Sep 4, 2023
Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)
Recruiting
- Axial Spondyloarthritis
- Blood sample
- +2 more
-
Besançon, FranceCentre Hospitalier Universitaire de Besançon
May 31, 2022
Evan Syndrome, Treatment Trial in Tianjin (Anti-CD38 antibody Injection)
Recruiting
- Evan Syndrome
- Treatment
- Anti-CD38 antibody Injection
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 25, 2023
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Apr 21, 2023
Childhood Asthma With Acute Exacerbation Trial in Gentofte, Naestved (Azithromycin, Placebo mixture)
Active, not recruiting
- Childhood Asthma With Acute Exacerbation
- Azithromycin
- Placebo mixture
-
Gentofte, Copenhagen, Denmark
- +1 more
Nov 21, 2022
Periodontitis Trial in Ljubljana (SRP+LASER (Dentsply Sirona - SIROLaser Blue), SRP+HA, SRP)
Recruiting
- Periodontitis
- SRP+LASER (Dentsply Sirona - SIROLaser Blue)
- +2 more
-
Ljubljana, SloveniaUniverity Medical Center Ljubljana
Jun 7, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Enfortumab vedotin
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 24, 2023
Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Tumors Trial in Worldwide (AZD9592, Osimertinib)
Recruiting
- Advanced Solid Tumours
- +2 more
-
Duarte, California
- +13 more
Jan 5, 2023
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Advanced Solid Malignancies Trial in Worldwide (AZD9574, Temozolomide)
Recruiting
- Advanced Solid Malignancies
-
La Jolla, California
- +30 more
Dec 20, 2022
Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)
Not yet recruiting
- Advanced Solid Tumours That Are MTAP Deficient
-
New Haven, Connecticut
- +3 more
Nov 8, 2023
Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)
Recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Avelumab
- +3 more
-
Coeur d'Alene, Idaho
- +19 more
Oct 4, 2022